Donate

Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
FEC-T chemotherapy

FEC-T chemotherapy (February 2019)

This booklet explains what the chemotherapy combination FEC-T is, when it may be prescribed, how it is given and what side effects may occur. FEC-T is a combination of four chemotherapy drugs: 5 fluorouracil (also known as 5FU); epirubicin; cyclophosphamide; docetaxol (also known as Taxotere).

Author(s)
Breast Cancer Care
Place of publication
London
Publisher
Breast Cancer Care
Date of publication
February 2019
Pages
20pp
Edition
2nd edition
Order reference
Supplier
https://breastcancernow.org/
Subject(s)
Breast cancer, Chemotherapy drugs, Combination chemotherapy, FEC-T chemotherapy, Cyclophosphamide, Fluorouracil (5FU), 5FU, Epirubicin, Docetaxel
Format
Booklet
Language
English
Flesch readability score
60.7
Download this resource
Download this resource
Back to results
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Donate

About this site

Macmillan sites

Right there with you

We're here to provide physical, financial and emotional support. So whatever cancer throws your way, we're right there with you. Contact us

Follow us

© Macmillan Cancer Support 2019 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 89 Albert Embankment, London SE1 7UQ. VAT no: 668265007